Schonfeld Strategic Advisors LLC increased its holdings in Genpact Limited (NYSE:G - Free Report) by 424.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 48,744 shares of the business services provider's stock after acquiring an additional 39,447 shares during the period. Schonfeld Strategic Advisors LLC's holdings in Genpact were worth $2,094,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in Genpact by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock valued at $728,539,000 after buying an additional 61,376 shares during the last quarter. Victory Capital Management Inc. increased its stake in Genpact by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock valued at $423,205,000 after buying an additional 1,511,790 shares during the last quarter. Franklin Resources Inc. increased its stake in Genpact by 1.3% in the 4th quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock valued at $180,560,000 after buying an additional 55,771 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Genpact by 5.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,848,449 shares of the business services provider's stock valued at $165,288,000 after buying an additional 208,759 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in Genpact by 3.6% in the 4th quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock valued at $170,175,000 after buying an additional 133,938 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Genpact Stock Performance
G traded up $0.41 on Friday, hitting $42.45. The company's stock had a trading volume of 3,113,784 shares, compared to its average volume of 1,354,468. The company's 50 day simple moving average is $48.74 and its 200-day simple moving average is $47.07. The firm has a market cap of $7.46 billion, a P/E ratio of 14.95, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. Genpact's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period last year, the firm earned $0.73 EPS. Analysts forecast that Genpact Limited will post 3.21 EPS for the current year.
Insider Buying and Selling at Genpact
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 3.07% of the company's stock.
Analysts Set New Price Targets
G has been the subject of a number of research reports. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and increased their target price for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Needham & Company LLC reduced their target price on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday. Robert W. Baird reduced their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and increased their target price for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Mizuho increased their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $50.71.
Get Our Latest Report on Genpact
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.